Biodexa Pharmaceuticals plc ADS/$BDRX
1D1W1MYTD1Y5YMAX
Capital at risk
About Biodexa Pharmaceuticals plc ADS
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
- Ticker
- $BDRX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 11
- Headquarters
- Cardiff, United Kingdom
- Website
- www.biodexapharma.com
BDRX Metrics
BasicAdvanced
$823K
-
-
-
-
Price and volume
Market cap
$823K
52-week high
$5.08
52-week low
$0.61
Average daily volume
7.6M
Financial strength
Current ratio
2.409
Quick ratio
2.409
Interest coverage (TTM)
-56.66%
Profitability
EBITDA (TTM)
-11.828
Effective tax rate (TTM)
-2.41%
Management effectiveness
Return on assets (TTM)
-40.11%
Return on equity (TTM)
-42.00%
Valuation
Growth
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.